共 48 条
[1]
Deramo VA(2003)Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire Arch Ophthalmol 121 1297-1302
[2]
Cox TA(2011)The burden of disease of retinal vein occlusion: review of the literature Eye (Lond) 25 981-988
[3]
Syed AB(2016)Retinal vein occlusions, from basics to the latest treatment Retina 36 432-448
[4]
Lee PP(2011)Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 1594-1602
[5]
Fekrat S(2011)Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2041-2049
[6]
Laouri M(2014)Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study Ophthalmology 121 2432-2442
[7]
Chen E(2012)Visual acuity outcome and predictive factors after bevacizumab for central retinal vein occlusion Eur J Ophthalmol 22 1013-1018
[8]
Looman M(2014)Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials Ophthalmology 121 1059-1066
[9]
Gallagher M(2009)Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials Invest Ophthalmol Vis Sci 50 3629-3635
[10]
Ho M(2010)Legal vision requirements for drivers in the United States Virtual Mentor 12 938-940